Try our Advanced Search for more refined results
June 21, 2013
Pfizer Inc. et al v. Sandoz Inc., et al
Case Number:
1:13-cv-01110
Court:
Nature of Suit:
Judge:
Firms
- Abrams & Bayliss
- Greenberg Traurig
- Heyman Enerio
- Morris Nichols
- Phillips McLaughlin
- Potter Anderson
- Prickett Jones
- Richards Layton
- Shaw Keller
- Young Conaway
Companies
- Alkem Laboratories Ltd.
- Amerigen Pharmaceuticals Ltd.
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Impax Laboratories, Inc.
- Lupin Ltd.
- Pfizer Inc.
- UCB SA
- Wockhardt Bio AG
- Wockhardt USA LLC
- Zydus Pharmaceuticals Inc.
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 20, 2016
Sandoz Loses Bid To Invalidate IP In Toviaz Row With Pfizer
A Delaware federal judge on Wednesday upheld the validity of five patents licensed by Pfizer Inc. protecting its Toviaz overactive-bladder treatment, dealing a blow to Sandoz Inc. and other drug companies accused of infringement in Pfizer's consolidated suit.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login